| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-2999(97)81924-3 |
| P698 | PubMed publication ID | 9424015 |
| P2093 | author name string | L S Harris | |
| M D Aceto | |||
| E R Bowman | |||
| P2860 | cites work | Actions of etorphine hydrochloride, (M99): a potent morphine-like agent | Q28364330 |
| Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment | Q33782677 | ||
| Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine | Q34054548 | ||
| Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists) | Q36400557 | ||
| Caffeine elicited withdrawal signs in morphine-dependent rhesus monkeys | Q40171073 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| The Effects of Naloxone and Nalorphine during the Development of Morphine Dependence in Rhesus Monkeys | Q41232421 | ||
| After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside | Q44331421 | ||
| Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance | Q44332228 | ||
| Opioid receptor interaction and adenylyl cyclase inhibition of dihydroetorphine: direct comparison with etorphine | Q44334917 | ||
| Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists | Q44335084 | ||
| Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence | Q44337423 | ||
| Dual regulation by mu, delta and kappa opioid receptor agonists of K+ conductance of DRG neurons and neuroblastoma X DRG neuron hybrid F11 cells | Q44341255 | ||
| Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells | Q44344759 | ||
| Characterization of opioid receptors in nervous tissue | Q44352061 | ||
| In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method | Q45719813 | ||
| The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties | Q46698394 | ||
| Unidirectional non-cross-tolerance (UNCT) in rats and an apparent dissociation between narcotic tolerance and physical dependence | Q48520800 | ||
| 3H-etorphine and 3H-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate | Q48884024 | ||
| Etorphine in man. I. Subjective effects and suppression of morphine abstinence | Q51300051 | ||
| The biological, social and clinical bases of drug addiction: commentary and debate. | Q52274270 | ||
| Dihydroetorphine, a potent opioid with low dependent potential | Q63244978 | ||
| Dihydroetorphine is a mu-receptor-selective ligand | Q70956088 | ||
| Antinociceptive effect of dihydroetorphine in diabetic mice | Q72296911 | ||
| Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice | Q72556401 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| physical dependence | Q2622112 | ||
| P304 | page(s) | 215-223 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity | |
| P478 | volume | 338 |
| Q38975808 | Analgesic activity of Eugenia jambolana leave constituent: a dikaempferol rhamnopyranoside from ethyl acetate soluble fraction |
| Q34477079 | Anti-allodynic actions of intravenous opioids in the nerve injured rat: potential utility of heroin and dihydroetorphine against neuropathic pain. |
| Q44000148 | Biochemical characterisation of newly developed beta-etorphine and beta-dihydroetorphine derivatives |
| Q41881067 | Central Antinociceptive and Mechanism of Action of Pereskia bleo Kunth Leaves Crude Extract, Fractions, and Isolated Compounds |
| Q41134315 | Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands |
| Q34164632 | Dihydroetorphine: a potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical effects |
| Q44867443 | Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat. |
| Q44911815 | Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats |
| Q43070514 | Endogenous opiates: 1997. |
| Q34001543 | Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor |
| Q41874430 | Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines. |
| Q44350368 | Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions |
| Q36822435 | Orvinols with mixed kappa/mu opioid receptor agonist activity |
| Q33566172 | Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418 |
| Q34363972 | Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082). |
| Q36170816 | Quinoline Alkaloids Isolated from Choisya Aztec-Pearl and Their Contribution to the Overall Antinociceptive Activity of This Plant. |
| Q39671329 | Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones |
| Q34063774 | The discriminative stimulus effects of mecamylamine in nicotine-treated and untreated rhesus monkeys |
Search more.